Page 3 - Best Aplastic anemia doctors: TOP 75 doctors

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Performed over 3,500 bone marrow transplants – recognized by Forbes as one of the best doctors in 2018.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating children with rare blood disorders
• Known among patients as 'the one who transplants life'
• Works at Hadassah Medical Center

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Spielberg is a dedicated oncohematologist at Assuta Medical Center, specializing in blood disorders like aplastic anemia.

• He focuses on both diagnosis and comprehensive treatment planning
• Expert in managing bone marrow failure syndromes
• Works at Israel's largest private hospital, Assuta Medical Center
• Provides personalized care for complex hematological conditions

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL), with over 100 published articles and ongoing participation in 80+ clinical trials.

• Heads Haematology at Vall d'Hebron University Hospital
• Specializes in new treatments for lymphoproliferative disorders
• PhD research focused on chronic lymphoproliferative disorders
• President of Spanish group for CLL study (GELLC)
• Post-doctoral fellowship at Columbia University, New York

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology – focused on advanced treatments at Emsey Hospital.

• Specializes in hematology and bone marrow transplantation
• Trained in molecular hematology at Japan Mie Medical School
• Professor of hematology with decades of academic experience
• Has presented at 34 international conferences

Dr. Apak specializes in pediatric hematology-oncology with 26 years of experience of experience, focusing on bone marrow transplantation and CAR T-cell therapy at Biruni University Hospital.

• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Authored 75 international publications in pediatric oncology
• Assistant editor for Turkish Pediatrics Archives Periodical
• Board member of Turkish Pediatric Society

Specializing in chronic leukemia and myeloproliferative diseases, Dr. Dogu brings extensive hematology expertise to Liv Hospital Ulus.

• Associate Professor at Istanbul Training and Research Hospital Hematology Clinic
• Member of the Turkish Society of Hematology and The Society of Hematological Education and Research
• Published 32 international articles and 12 cases in peer-reviewed journals
• Hematology specialist with over a decade of focused experience

Prof. Baytan specializes in pediatric hematology and oncology, with a focus on childhood cancers and bone marrow transplantations at Emsey Hospital.

• 15 articles published in international refereed journals
• Expert in anemia treatments and iron deficiency
• Professor at Uludağ University with extensive academic roles
• Specializes in pediatric bone marrow transplantations

Associate Professor Rafet Eren specializes in hematology with 50+ publications in international journals, reflecting deep expertise in blood disorders.

• Completed PhD in Hematology at Istanbul Training and Research Hospital
• Member of European Society of Hematology
• Won the Young Researcher Award in 2016
• Fluent in English for international consultations

Pediatric hematologist-oncologist specializing in aplastic anemia and bone marrow transplants.

• Expertise in pediatric hematology and oncology
• Specializes in bone marrow transplantation
• Focuses on treating children with aplastic anemia

Associate Professor Ali Hakan Kaya specializes in hematology and stem cell transplants, with extensive training at top Turkish hospitals.

• Subspecialist in hematology with focus on stem cell transplantation
• Multiple award-winning researcher in hematologic oncology
• Member of Turkish Apheresis Society and Hematologic Immunology Society
• Works at Biruni University Hospital's advanced hematology department

Specializing in bone marrow failure disorders, Dr. Itir Sirinoglu Temiz leads the hematology department at Liv Hospital Vadistanbul.

• Over 36 years of experience of experience in hematology and stem cell transplantation
• Expertise in therapeutic apheresis for blood disorders
• Former education and administrative manager at leading hematology clinics
• Published researcher with focus on leukemia and myeloma